Shanghai, China – From May 25 to May 28, Shanghai MicroPort Medical (Group) Co., Ltd. ("MicroPort®") attended the 11th Oriental Congress of Cardiology ("OCC 2017") in Shanghai Expo Center and hosted a satellite meeting and a case contest. The OCC 2017 was hosted by Shanghai Medical Association and Chinese Society of Cardiology, focusing on the development and application of modern science in the field of cardiovascular diseases, while providing cardiologists a platform for academic exchange.
On May 27, MicroPort® hosted a satellite meeting – "The Rhythm of MicroPort®: the Latest Clinical Data of TARGET Series Studies," co-chaired by Professor Jinghua Liu of Beijing Anzhen Hospital of Capital Medical University, Professor Yin Liu of Tianjin Chest Hospital, Professor Zuyi Yuan of the First Affiliated Hospital of Xi'an Jiaotong University and Professor Xianxian Zhao of Changhai Hospital of the Second Military Medical University. During the satellite meeting, Professor Bo Xu of Fuwai Hospital of Chinese Academy of Medical Sciences released the three-month Optical Computerized Tomography ("OCT") data from the TARGET All Comer trial for Firehawk® Rapamycin Target Eluting Coronary Stent System ("Firehawk®"). TARGET All Comer is the first post-market randomized trial in 10 European countries for Firehawk®. The TARGET All Comer study started in December 2015 and completed its enrollment in October 2016. A total of 1,656 patients were enrolled, including pre-specified 50 in the OCT sub-study and 176 in a QCA sub-study (13-month follow-up). During the meeting, Professor Jinjie Dai of Shanghai Chest Hospital, Professor Huimin Liu of the Second Affiliated Hospital of Harbin Medical University, and Professor Kun Wang of Nanjing Drum Tower Hospital also shared some cases using Firehawk® to further demonstrate its excellent performance in clinical application, which was well received by experts in attendance.
During the OCC 2017, MicroPort® displayed coronary stents, balloons, accessories, Columbus™ 3D EP Navigation System (Columbus™) and other products in its booth, and meanwhile set up the VR experience center in MicroPort® booth which provided visitors a more vivid understanding in the innovative technology of Firehawk® and attracted a lot of attention from the attendees. Besides, electrophysiologists including Professor Feifan Ouyang of St. Georg Hospital in Germany, Professor Zulu Wang from the General Hospital of Shenyang Military, Professor Yunlong Xia of the First Affiliated Hospital of Dalian Medical University, Professor Zheng Zhang of the First Hospital of Lanzhou University, Professor Yuehui Yin of the Second Affiliated Hospital of Chongqing Medical University, and Professor Jinlin Zhang of Wuhan Asia Cardiovascular Disease Hospital also visited MicroProt® booth to experience the performance of Columbus™. They expressed their expectations on the future innovations of MicroPort® and other domestic medical device companies, so that more high-end medical devices could be developed to benefit Chinese patients suffering from cardiovascular diseases.
Privacy settings
This website may store cookies on your browser. Cookies are mostly used to make the website work as you expect it to. No cookie will directly identify you, but it can give you a more personalized browsing experience.
MicroPort respects your privacy rights, so you can block some types of cookies. Technically non-essential cookies and tracking mechanisms, that enable us to provide you with customized offers (marketing cookies), are only used if you have given prior consent to such use.
By clicking “Save”, only the cookies you selected will be used. You can withdraw the consent that you granted here at any time by going to Cookies Settings.
For more information, please see our Cookie Policy.